| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Ronald Ching Wan Ma | Q43809750 |
| P2093 | author name string | Ronald C W Ma | |
| P2860 | cites work | Genomics of Cardiovascular Disease | Q22248110 |
| Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 | ||
| The role of epigenetics in the pathology of diabetic complications | Q24609124 | ||
| New loci associated with kidney function and chronic kidney disease | Q24630646 | ||
| Challenges in elucidating the genetics of diabetic retinopathy | Q26998699 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Chronic kidney disease as a risk factor for coronary artery disease in Chinese with type 2 diabetes | Q46891348 | ||
| Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth | Q47424075 | ||
| The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). | Q47861452 | ||
| Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population. | Q51493325 | ||
| Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. | Q51914338 | ||
| Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects. | Q53087421 | ||
| Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism. | Q54623917 | ||
| Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. | Q54654030 | ||
| Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis | Q58209408 | ||
| Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy | Q28241871 | ||
| Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes | Q28272915 | ||
| Multiple loci associated with indices of renal function and chronic kidney disease | Q28943262 | ||
| Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study | Q28943465 | ||
| Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility | Q29417007 | ||
| New susceptibility loci associated with kidney disease in type 1 diabetes | Q29417066 | ||
| A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants | Q29547210 | ||
| A common variant on chromosome 9p21 affects the risk of myocardial infarction | Q29614954 | ||
| 10-year follow-up of intensive glucose control in type 2 diabetes | Q29615973 | ||
| Diabetic nephropathy--what are the unmet needs? | Q30372943 | ||
| An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes | Q30417141 | ||
| Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy | Q30434280 | ||
| Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes | Q30435965 | ||
| Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans | Q30436877 | ||
| Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes | Q30548796 | ||
| Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial | Q30651606 | ||
| A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes | Q30978054 | ||
| The relationship between proteinuria and coronary risk: a systematic review and meta-analysis | Q33378672 | ||
| Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients | Q33556747 | ||
| Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008 | Q33602366 | ||
| Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans | Q33623998 | ||
| Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus | Q33650362 | ||
| Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) | Q33764951 | ||
| Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes | Q34024371 | ||
| Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. | Q34042700 | ||
| Genetic loci influencing kidney function and chronic kidney disease | Q34109552 | ||
| Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes | Q34127486 | ||
| Genetic associations in diabetic nephropathy: a meta-analysis | Q34153165 | ||
| Genetic risk score associations with cardiovascular disease and mortality in the Diabetes Heart Study | Q34259420 | ||
| Genetic susceptibility to macrovascular complications of type 2 diabetes mellitus | Q34367999 | ||
| Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. | Q34437314 | ||
| Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy | Q34455119 | ||
| Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes | Q34691015 | ||
| Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study | Q34803998 | ||
| Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and β3-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes-an 8-year prospective cohort analysis of 1297 patients | Q58209604 | ||
| The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients | Q58793815 | ||
| Coincident Linkage of Type 2 Diabetes, Metabolic Syndrome, and Measures of Cardiovascular Disease in a Genome Scan of the Diabetes Heart Study | Q59353948 | ||
| Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects | Q61771206 | ||
| Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy | Q67745344 | ||
| Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group | Q73842153 | ||
| ELMO1 increases expression of extracellular matrix proteins and inhibits cell adhesion to ECMs | Q79190003 | ||
| Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms | Q79207800 | ||
| Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis | Q79843201 | ||
| Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians | Q79989173 | ||
| Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus | Q80001840 | ||
| Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts | Q83393056 | ||
| Chronic kidney disease and GWAS: "the proper study of mankind is man" | Q84344552 | ||
| Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998-2009 | Q87208936 | ||
| Diabetes in South-East Asia: an update. | Q40155026 | ||
| Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy | Q41306582 | ||
| Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study | Q41776334 | ||
| Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort | Q42202570 | ||
| Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population. | Q43526265 | ||
| Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: evidence for linkage of triglyceride levels to chromosome 19q. | Q43867583 | ||
| Heritability of carotid artery intima-medial thickness in type 2 diabetes | Q44053941 | ||
| Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). | Q44233624 | ||
| Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes | Q44585580 | ||
| The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes | Q44666346 | ||
| Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study | Q44816784 | ||
| Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). | Q45014719 | ||
| Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study | Q45108289 | ||
| Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. | Q45242349 | ||
| Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes | Q45300884 | ||
| Microvascular disease: what does the UKPDS tell us about diabetic retinopathy? | Q45815750 | ||
| Ethnic disparities in diabetic complications in an insured population | Q46567646 | ||
| Analysis of quantitative lipid traits in the genetics of NIDDM (GENNID) study | Q46722542 | ||
| Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus | Q46727650 | ||
| Effect of a multifactorial intervention on mortality in type 2 diabetes | Q46767642 | ||
| Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials | Q34982751 | ||
| Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people | Q35004093 | ||
| Molecular understanding of hyperglycemia's adverse effects for diabetic complications | Q35005662 | ||
| An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes | Q35050146 | ||
| Diabetes complications: the microRNA perspective. | Q35063237 | ||
| Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus | Q35189556 | ||
| Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes | Q35405420 | ||
| Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells | Q35451716 | ||
| Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies | Q35619428 | ||
| Adiponectin: A novel adipokine linking adipocytes and vascular function | Q35794441 | ||
| Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study | Q35898244 | ||
| Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy | Q36109264 | ||
| Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies | Q36347919 | ||
| Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations | Q36533958 | ||
| Vascular complications of diabetes: mechanisms of injury and protective factors | Q36537262 | ||
| Large-scale association analysis identifies new risk loci for coronary artery disease | Q36921066 | ||
| Impact of HDL genetic risk scores on coronary artery calcified plaque and mortality in individuals with type 2 diabetes from the Diabetes Heart Study. | Q36964375 | ||
| Genetic factors in diabetic nephropathy | Q36974103 | ||
| Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry | Q36975722 | ||
| Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis | Q37166321 | ||
| Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes | Q37382378 | ||
| Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes | Q37387934 | ||
| New insights into molecular mechanisms of diabetic kidney disease | Q37598306 | ||
| National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events | Q37780943 | ||
| Epigenetic phenomena linked to diabetic complications. | Q37806609 | ||
| Mechanisms of diabetic complications. | Q38072902 | ||
| Circulating microRNAs as novel biomarkers for diabetes mellitus | Q38102924 | ||
| MicroRNAs and metabolism crosstalk in energy homeostasis | Q38121322 | ||
| Current Insights into the Joint Genetic Basis of Type 2 Diabetes and Coronary Heart Disease. | Q38204372 | ||
| Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond | Q38214522 | ||
| Diabetes in the Western Pacific Region--past, present and future | Q39273729 | ||
| Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database | Q39690519 | ||
| A single nucleotide polymorphism in KCNQ1 is associated with susceptibility to diabetic nephropathy in japanese subjects with type 2 diabetes. | Q39784426 | ||
| Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals | Q39982494 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| complications of diabetes mellitus | Q4198677 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 139-154 | |
| P577 | publication date | 2015-08-26 | |
| P1433 | published in | Journal of Diabetes Investigation | Q28207066 |
| P1476 | title | Genetics of cardiovascular and renal complications in diabetes | |
| P478 | volume | 7 |
| Q64077515 | Efficacy of traditional Chinese medication Tangminling pill in Chinese patients with type 2 diabetes |
| Q55091653 | Genetics of Diabetic Kidney Disease-From the Worst of Nightmares to the Light of Dawn? |
| Q89695426 | Long Non-Coding RNA (LncRNA) CASC15 Is Upregulated in Diabetes-Induced Chronic Renal Failure and Regulates Podocyte Apoptosis |
| Q52677048 | Precision medicine in diabetes prevention, classification and management. |
| Q55088424 | Targeting glucose metabolism for healthy aging. |
| Q37733530 | The Association of a Genetic Variant in SCAF8-CNKSR3 with Diabetic Kidney Disease and Diabetic Retinopathy in a Chinese Population. |
| Q50125105 | The Effects of Chronic Aerobic Exercise on Cardiovascular Risk Factors in Persons with Diabetes Mellitus |
| Q46773662 | Therapeutic Approaches and Role of ncRNAs in Cardiovascular Disorders and Insulin Resistance. |
| Q47701069 | Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links. |
| Q39446720 | Vascular complications in diabetes: old messages, new thoughts |
Search more.